Michael A. Gordon, Ph.D.

Abbreviated Curriculum Vitae

← Pharmacology2000.com

Education

1969 – 1971
A.B. in Neurosciences Indiana University
1971 – 1972
Graduate Research Fellowship in Neurophysiology University of Pisa, Pisa, Italy National Research Council Institute of Physiology / Institute of Human Physiology
1972
M.Sc. in Biochemistry (Neurochemistry) University of London, London, England Department of Biochemistry
1973 – 1976
Ph.D. in Pharmacology University of California, San Francisco (UCSF) Department of Pharmacology

Academic Appointments

1976 – 1978
Post-Doctoral Research Associate University of Colorado, Boulder Department of Chemistry
1978 – 1982
Assistant Professor and Section Head of Pharmacology (1980–1982) University of South Dakota School of Medicine Section of Pharmacology, Division of Biochemistry, Physiology and Pharmacology
1982 – 1985
Assistant Professor of Pharmacology University of Kansas Medical Center (KUMC) Department of Pharmacology, Toxicology and Therapeutics
1985 – 2000
Associate Professor of Pharmacology University of Kansas Medical Center (KUMC) Department of Pharmacology, Toxicology and Therapeutics. Adjunct appointments: Division of Neurosurgery; Department of Nurse Anesthesia; School of Nursing.
2000 – 2006
Associate Professor University of Kansas Medical Center (KUMC) Department of Nurse Anesthesia Education, School of Allied Health

Teaching Experience

1979 – 1982
Course Director, Medical Pharmacology Basic Course University of South Dakota School of Medicine Section Head of Pharmacology. Responsible for course scheduling, lectures in cardiovascular and autonomic pharmacology, and examination development.
1983 – 1997
CNS Unit Chairman, Medical Pharmacology Course University of Kansas Medical Center Block Leader, Blood-Endocrine-CNS Block (1985–1992); Block Leader Block II — Autacoids, CNS, CVR (1992–1997).
1982 – 2006
Graduate and Professional Courses University of Kansas Medical Center CNS Pharmacology Graduate Core Course; Molecular Pharmacology; Essentials of Pharmacology (Course Director, 1998); Nursing Pharmacology; Nurse Anesthesia Pharmacology 850, 851, 852 (online, 2000–2006).
1996 – present
Online Medical Pharmacology Education Pharmacology2000.com Developer and sole author of Pharmacology2000.com, an online medical pharmacology resource comprising approximately 22,000 board-style questions across 41 chapters of clinical pharmacology, designed for medical residents, clinicians, and advanced students. Approximately 7.5 million lifetime visits.

Book

Enna, S.J., Pazdernik, T.L. and Gordon, M.A. (eds.). Board Review Book in Pharmacology: ACE The Boards. 1996.

Selected Publications

  1. Gordon, M.A. and Burdick, H.C.: On a procedure for the determination of the lethal myocardial concentration of epinephrine in the white rat. Arch. Int. Pharmacodyn. 170, 468–472, 1967.
  2. Gordon, M., Rubia, F.J. and Strata, P.: Sensitivity to pentothal of a synapse in the cerebellar cortex. Arch. Fisiol. 68, 330, 1972.
  3. Gordon, M., Ubin, R.J. and Strata, P.: The effect of barbiturate anesthesia on the transmission to the cerebellar cortex. Brain Res. 43, 677–680, 1972.
  4. Gordon, M.A., et al.: Active-site determination on forms of mammalian brain and eel acetylcholinesterase forms. Biochem. J. 157, 69–76, 1976.
  5. Gordon, M.A., Settle, W.L., Chan, S.-L. and Trevor, A.J.: Kinetic analysis of calcium activation of brain acetylcholinesterase forms. Biochim. Biophys. Acta 485, 101–115, 1977.
  6. Gordon, M., Carpenter, D.E. and Wilson, I.B.: The turnover numbers of acetylcholinesterase forms. Mol. Pharmacol. 14, 266–270, 1978.
  7. Gordon, M.A., Cohen, J.J. and Wilson, I.B.: Muscarinic cholinergic receptors in murine lymphocytes: demonstration by direct binding. Proc. Natl. Acad. Sci. (USA) 75, 2902–2904, 1978.
  8. Johnson, D.L. and Gordon, M.A.: Characteristics of adrenergic binding sites associated with murine lymphocytes isolated from spleen. J. Immunopharmacology 2(4), 435–452, 1980.
  9. Audus, K.L. and Gordon, M.A.: Tricyclic antidepressant effects on the murine lymphocyte mitogen response. J. Immunopharmacology 4(1–2), 1–12, 1982.
  10. Audus, K.L. and Gordon, M.A.: Characteristics of tricyclic antidepressant binding sites associated with murine lymphocytes. J. Immunopharmacology 4(1–2), 13–27, 1982.
  11. Audus, K.L. and Gordon, M.A.: Effect of tricyclic antidepressant drugs on lymphocyte membrane structure. J. Immunopharmacology 6, 105–132, 1984.
  12. Lavid, N.E., et al. (including Gordon, M.A.): Analysis of three-dimensional computerized representations of articular cartilage lesions. Investigative Radiology 31(9), 577–585, 1996.
  13. Pope, T.W., et al. (including Gordon, M.A.): Texture analysis of cerebral white matter in SIV-infected macaque monkeys. Journal of Neuroscience Methods 74, 53–64, 1997.
  14. Burns, J.M., et al. (including Gordon, M.A.): Analysis of pallidotomy lesion positions using three-dimensional reconstruction. Neurosurgery 41(6), 1303–1318, 1997.
  15. Kirschman, D., et al. (including Gordon, M.A.): Pallidotomy microelectrode targeting: neurophysiology-based target refinement. Neurosurgery 46(3), 613–624, 2000.
  16. Sise, C., et al. (including Gordon, M.A.): Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. Kidney International 58(6), 2000.
  17. Park, M., Belhaj-Saif, A., Gordon, M., and Cheney, P.: Consistent features in the forelimb representation of primary motor cortex in rhesus macaques. Journal of Neuroscience 21(8), 2784–2792, 2001.
  18. Cheng, C. and Gordon, M.: An interesting observation of the position of some electronegative atoms in the taxol molecule. Medical Hypothesis 54(2), 172–176, 2000.

Full publication list available on request. Total: 40+ peer-reviewed publications.